Fortem Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-819
| Closed | -$591K | – | 161 |
|
|
2022
Q4 | $591K | Hold |
819
| – | – | 0.35% | 87 |
|
|
2022
Q3 | $564K | Sell |
819
-160
| -16% | -$110K | 0.39% | 79 |
|
|
2022
Q2 | $579K | Sell |
979
-3,702
| -79% | -$2.19M | 0.38% | 86 |
|
|
2022
Q1 | $3.27M | Buy |
4,681
+800
| +21% | +$559K | 1.43% | 14 |
|
|
2021
Q4 | $2.45M | Buy |
3,881
+42
| +1% | +$26.5K | 1.12% | 28 |
|
|
2021
Q3 | $2.32M | Buy |
3,839
+106
| +3% | +$64.1K | 1.18% | 24 |
|
|
2021
Q2 | $2.09M | Buy |
3,733
+1,296
| +53% | +$724K | 1.06% | 28 |
|
|
2021
Q1 | $1.15M | Buy |
2,437
+62
| +3% | +$29.3K | 0.67% | 58 |
|
|
2020
Q4 | $1.15M | Sell |
2,375
-124
| -5% | -$59.9K | 0.69% | 47 |
|
|
2020
Q3 | $1.4M | Buy |
+2,499
| New | +$1.4M | 1.01% | 34 |
|